Chu, Fuliang
Li, Haiyan S. http://orcid.org/0000-0001-5069-9735
Liu, Xindong
Cao, Jingjing
Ma, Wencai
Ma, Ying
Weng, Jinsheng
Zhu, Zheng
Cheng, Xiaoyun
Wang, Zhiqiang
Liu, Jingwei
Jiang, Zi Yang
Luong, Amber U.
Peng, Weiyi
Wang, Jing
Balakrishnan, Kumudha
Yee, Cassian
Dong, Chen
Davis, Richard Eric
Watowich, Stephanie S.
Neelapu, Sattva S.
Funding for this research was provided by:
Oversea Development Program
NIH National Institute of Allergy and Infectious Diseases
Leukemia and Lymphoma Society (P-QFC-3068-14)
Leukemia and Lymphoma Society Quest for Cure Grant
Article History
Received: 29 December 2018
Revised: 6 March 2019
Accepted: 8 March 2019
First Online: 25 April 2019
Compliance with ethical standards
:
: SSN has received research support from Kite/Gilead, Celgene, Cellectis, Poseida, Merck, Acerta, Karus, and BMS; served as consultant and advisory board member for Kite/Gilead, Celgene, Novartis, Unum Therapeutics, Pfizer, and Merck. The remaining authors declare that they have no conflict of interest.